Robert Pietrusko

Robert Pietrusko is an accomplished regulatory affairs executive with extensive experience in the pharmaceutical industry. Serving as Chief Regulatory Officer at DBV Technologies since May 2024 and at Vor Bio from April 2020 to April 2024, Robert has a proven track record in overseeing regulatory strategies and interactions with global regulatory agencies, including the FDA. Prior roles include Senior Vice President for Regulatory Affairs and Quality Assurance at Voyager Therapeutics, VP of Global Regulatory Affairs and Quality at ViroPharma, and Senior Vice President of Worldwide Regulatory Affairs at Millennium Pharmaceuticals, where Robert played a vital role in product approvals in both the US and EU. Robert's career commenced in academia as an instructor at The Ohio State University and continued as Director of the Susquehanna Pharmaceutical Profile Center at The Williamsport Hospital. Educational background includes a Doctor of Pharmacy from the University of the Sciences in Philadelphia and a Pharmacy residency at Jefferson Health.